» Articles » PMID: 2183891

Autocrine and Paracrine Growth Regulation of Breast Cancer: Clinical Implications

Overview
Specialty Oncology
Date 1990 Jan 1
PMID 2183891
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Research using experimental models of human breast cancer has broadened our understanding of the possible biochemical pathways regulating breast cancer growth. Breast cancer cells express receptors for and respond to a variety of steroid and polypeptide hormones and growth factors. Specific oncogenes are also expressed in breast cancer cells, and levels of expression may relate to tumor growth and aggressiveness. Recent studies have shown that breast cancer cells can even synthesize and secrete various growth factors that could stimulate tumor growth through autocrine and/or paracrine mechanisms. Secretion of some of these growth factors is regulated by estrogen, providing a possible mechanism for estrogen induced growth. Knowledge of these growth regulatory pathways has potentially important clinical implications. Blockade of these pathways offers new possible treatment strategies, much as antiestrogens have been used to inhibit tumor growth. Quantification of the expression of certain oncogenes, growth factor receptors, or the growth factors themselves, may provide prognostic information for the individual patient. Finally, it is plausible that measurement of these tumor products in body fluids might provide tumor markers that are useful in the diagnosis and treatment of breast cancer.

Citing Articles

Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer.

Zhou B, Peyton M, He B, Liu C, Girard L, Caudler E Cancer Cell. 2006; 10(1):39-50.

PMID: 16843264 PMC: 4451119. DOI: 10.1016/j.ccr.2006.05.024.


Biochemical and ultrastructural features of human milk and nipple aspirate fluids.

Malatesta M, Mannello F, Bianchi G, Sebastiani M, Gazzanelli G J Clin Lab Anal. 2001; 14(6):330-5.

PMID: 11138618 PMC: 6807916. DOI: 10.1002/1098-2825(20001212)14:6<330::aid-jcla14>3.0.co;2-p.


Responsiveness to hormone, growth factor and drug treatment of a human breast cancer cell line: comparison between early and late cultures.

DE CUPIS A, Pirani P, Fazzuoli L, Favoni R In Vitro Cell Dev Biol Anim. 1998; 34(10):836-43.

PMID: 9870534 DOI: 10.1007/s11626-998-0039-4.


Short-term primary culture of epithelial cells derived from human breast tumours.

Speirs V, Green A, Walton D, Kerin M, Fox J, Carleton P Br J Cancer. 1998; 78(11):1421-9.

PMID: 9836473 PMC: 2063218. DOI: 10.1038/bjc.1998.702.


Cell cycle expression of estrogen receptors determined by image analysis on human breast cancer cells in vitro and in vivo.

Rostagno P, Moll J, Birtwisle-Peyrottes I, Ettore F, Caldani C Breast Cancer Res Treat. 1996; 39(2):147-54.

PMID: 8872323 DOI: 10.1007/BF01806181.


References
1.
Huff K, Knabbe C, Lindsey R, Kaufman D, Bronzert D, Lippman M . Multihormonal regulation of insulin-like growth factor-I-related protein in MCF-7 human breast cancer cells. Mol Endocrinol. 1988; 2(3):200-8. DOI: 10.1210/mend-2-3-200. View

2.
Furlanetto R, DiCarlo J . Somatomedin-C receptors and growth effects in human breast cells maintained in long-term tissue culture. Cancer Res. 1984; 44(5):2122-8. View

3.
Hanauske A, Arteaga C, Clark G, Buchok J, Marshall M, Hazarika P . Determination of transforming growth factor activity in effusions from cancer patients. Cancer. 1988; 61(9):1832-7. DOI: 10.1002/1097-0142(19880501)61:9<1832::aid-cncr2820610919>3.0.co;2-j. View

4.
Nicholson S, Sainsbury J, Needham G, Chambers P, Farndon J, Harris A . Quantitative assays of epidermal growth factor receptor in human breast cancer: cut-off points of clinical relevance. Int J Cancer. 1988; 42(1):36-41. DOI: 10.1002/ijc.2910420108. View

5.
WELSCH C, Nagasawa H . Prolactin and murine mammary tumorigenesis: a review. Cancer Res. 1977; 37(4):951-63. View